| 姓名 | 職稱 | 持有股份 | 代表法人 |
|---|---|---|---|
| Zhan,Han-Shan | Chairman | 1.33% | YI TAI INVESTMENT CO., LTD. |
| Chen,Bing-Kun | Director | 0.00% | |
| CHIEN YEU ENTERPRISE CO., LTD. | Director | 0.00% | |
| Taipei Muse Co., Ltd. | Director | 36.60% | |
| Xiao,Wen-Feng | Independent Director | 0.00% | |
| Du,Yi-Yang | Independent Director | 0.00% | |
| Jiang,Mei-Ling | Independent Director | 0.00% |
Change Person in Charge to Zhan,Han-Shan
2024/05/28
Change Company Name to TIEN LIANG BIOTECH CO., LTD.
2023/07/12
Change Company Name to TIANLIANG BIOTECHNOLOGY ENTERPRISE CO., LTD. (FORMER NAME: TIANLIANG INTERNATIONAL ENTERPRISE CO., LTD.)
2020/07/27
Change Person in Charge to Shen,Xi-Cong
2017/07/14
Change Person in Charge to Ji,Yuan-Zhang
2014/07/16
下載完整報告查看完整數據
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Operating income | 116,602 | 385,206 | 459,993 |
| Operating cost | 47,551 | 155,292 | 173,845 |
| Profit (loss) of initial recognition of biological asset and agricultural products | - | - | - |
| Profit (loss) on changes in fair value less costs to sell of biological asset for current period | - | - | - |
| Operating gross profit (loss) | 69,051 | 229,914 | 286,148 |
| Unrealized profit (loss) on sales of goods | - | - | - |
| Realized profit (loss) on sales of goods | - | - | - |
| Operating gross profit (loss), net | 69,051 | 229,914 | 286,148 |
| Operating expenses | 60,806 | 229,321 | 265,712 |
| Other gain (loss), net | - | - | - |
| Operating profit (loss) | 8,245 | 593 | 20,436 |
| Non-operating income and expenses | 8,543 | 12,504 | -2,020 |
| Net profit (loss) before tax | 16,788 | 13,097 | 18,416 |
| Income tax expense (benefits) | -834 | 1,401 | 684 |
| Net profit (loss) of ongoing business for the current period | 17,622 | 11,696 | 17,732 |
| Profit (loss) of closed units | - | - | - |
| Profit (loss) of non-jointly controlled equity before merger | - | - | - |
| Net profit (loss) for the current period | 17,622 | 11,696 | 17,732 |
| Other comprehensive profit (loss), net | 2,509 | -3,875 | 126 |
| Comprehensive net profit and loss of non-jointly controlled equity before merger | - | - | - |
| Total comprehensive profit and loss for the current period | 20,131 | 7,821 | 17,858 |
| Net profit (loss) attributable to owners of parent company | 17,622 | - | - |
| Net profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Net profit (loss) attributable to non-controlling interests | - | - | - |
| Comprehensive profit (loss) attributable to owners of parent company | 20,131 | - | - |
| Comprehensive profit (loss) form equity attributable to former owner of business combination under common control | - | - | - |
| Comprehensive profit (loss) attributable to non-controlling interests | - | - | - |
| Basic earnings per share (yuan) | 0 | 0 | 0 |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net cash inflow (outflow) from operating activities | 24,699 | - | - |
| Net cash inflows (outflows) from investing activities | -128,056 | - | - |
| Net cash inflow (outflow) from financing activities | 119,875 | - | - |
| Effect of Exchange Rate Changes on Cash and Cash Equivalents | - | - | - |
| Increase (decrease) in cash and cash equivalents in the current period | 16,518 | - | - |
| Beginning balance of cash and cash equivalents | 130,667 | - | - |
| Ending balance of cash and cash equivalents | 147,185 | - | - |
| 項目 | 2025 | 2024 | 2023 |
|---|---|---|---|
| Current asset | 319,348 | 246,540 | 309,041 |
| Non-current asset | 745,249 | 642,142 | 344,994 |
| Total asset | 1,064,597 | 888,682 | 654,035 |
| Current liability | 564,369 | 407,383 | 144,849 |
| Non-current liability | 2,173 | 3,375 | 16,203 |
| Total liability | 566,542 | 410,758 | 161,052 |
| share capital | 457,600 | 457,600 | 457,600 |
| Equity - secruity token | - | - | - |
| capital reserve | 0 | 0 | 0 |
| retained earning | 50,550 | 32,928 | 35,383 |
| Other equity | -10,095 | -12,604 | - |
| Treasury stock | 0 | 0 | - |
| Total equity attributable to owners of parent company | 498,055 | - | - |
| Equity attributable to former owner of business combination under common control | - | - | - |
| Equity attributable to non-controlling interest before business merger under common control | - | - | - |
| Non-controlling interests | - | - | - |
| Total Equity | 498,055 | 477,924 | 492,983 |
| Share capital awaiting retirement (unit: share) | - | - | 0 |
| Issued shares of advance equity (unit: shares) | 0 | 0 | 0 |
| Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) | 0 | 0 | 0 |
| Net asset value per share | 10 | 10 | 10 |
Others
2009
Compensation for damage
2015
Determine legal expenses
2023
Declaration of confiscation
2020
Return parking spaces, etc.
2011
Compensation for damage, etc.
2017
Petition for confiscated independently may be pronounced separately
2020
Infringement of patent rights related to property rights disputes, etc.
2013
Others
2008, 2010
Payment order
2007, 2008
Litigation aid
2009
Pay for the goods
2012
Trademark Evaluation
2002, 2005, 2016
Invalidating Judgment
2006
Repay security deposit
2009
Trademark registration
2007
Compensation for damage
2018, 2020, 2021, 2022
Return security deposit
2016
Determine legal expenses
2013
Return parking spaces, etc.
2012
Compensation for damage, etc.
2017, 2018
Request for damage compensation
2023
Infringement of patent rights related to property rights disputes, etc.
2014
